Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Almonty Industries announces 1-for-1.5 share consolidation (SeekingAlpha) +++ ALMONTY Aktie +3,56%

GLOBUS MEDICAL Aktie

 >GLOBUS MEDICAL Aktienkurs 
51.5 EUR    (Tradegate)
Ask: 52 EUR / 97 Stück
Bid: 51 EUR / 99 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 8 bis 22 Uhr!
GLOBUS MED Aktie über LYNX handeln
>GLOBUS MEDICAL Performance
1 Woche: +2,9%
1 Monat: -1,4%
3 Monate: -25,7%
6 Monate: -36,3%
1 Jahr: -19,3%
laufendes Jahr: -35,5%
>GLOBUS MEDICAL Aktie
Name:  GLOBUS MED.A NEW DL -,001
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US3795772082 / A1J2LY
Symbol/ Ticker:  GM0N (Frankfurt) / GMED (NYSE)
Kürzel:  FRA:GM0N, ETR:GM0N, GM0N:GR, NYSE:GMED
Index:  -
Webseite:  http://www.globusmedical...
Marktkapitalisierung:  6870 Mio. EUR
Umsatz:  2173.14 Mio. EUR
EBITDA:  623.96 Mio. EUR
Gewinn je Aktie:  1.004 EUR
Schulden:  80.34 Mio. EUR
Liquide Mittel:  399.36 Mio. EUR
Umsatz-/ Gewinnwachstum:  -1.4% / -
KGV/ KGV lG:  44.15 / 18.76
KUV/ KBV/ PEG:  3.27 / 1.96 / 1.71
Gewinnm./ Eigenkapitalr.:  7.39% / 4.63%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  GLOBUS MEDICAL, GLOBUS MED
Letzte Datenerhebung:  03.07.25
>GLOBUS MED Eigentümer
Aktien: 112.95 Mio. St.
f.h. Aktien: 112.05 Mio. St.
Insider Eigner: 0.69%
Instit. Eigner: 100.7%
>GLOBUS MED Peer Group

 
15.05.25 - 22:42
 Globus Medical announces share buyback program of up to $500M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
15.05.25 - 22:33
 Globus Medical Announces $500 Million Share Repurchase Program (GlobeNewswire EN)
 
AUDUBON, Pa., May 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors has authorized a share repurchase program of up to $500 million of the Company's outstanding common stock....
09.05.25 - 04:36
 Globus medical outlines $2.8B-$2.9B 2025 revenue guidance amid Nevro integration (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
09.05.25 - 01:45
 Globus Medical (GMED) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
 
The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals....
09.05.25 - 01:00
 Globus Medical (GMED) Lags Q1 Earnings and Revenue Estimates (Zacks)
 
Globus Medical (GMED) delivered earnings and revenue surprises of -8.11% and 4.81%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?...
08.05.25 - 22:18
 Globus Medical Reports First Quarter 2025 Results (GlobeNewswire EN)
 
AUDUBON, Pa., May 08, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2025....
07.05.25 - 18:48
 Globus Medical Q1 2025 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.05.25 - 16:45
 Gear Up for Globus Medical (GMED) Q1 Earnings: Wall Street Estimates for Key Metrics (Zacks)
 
Beyond analysts' top -and-bottom-line estimates for Globus Medical (GMED), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025....
18.04.25 - 19:45
 Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report? (Zacks)
 
Globus Medical (GMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report....
17.04.25 - 22:33
 Globus Medical Schedules First Quarter Earnings Release and Conference Call (GlobeNewswire EN)
 
AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March 31, 2025 after the market close on Thursday, May 8, 2025. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com....
14.04.25 - 19:45
 International Growth Drives GMED Stock Amid Fierce Competition (Zacks)
 
Globus Medical is gearing up for a series of product launches throughout the Musculoskeletal portfolio in the coming months of 2025....
11.04.25 - 21:21
 Breaking Down Globus Medical: 5 Analysts Share Their Views (Benzinga)
 
Latest Ratings for GMED DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Feb 2022Credit SuisseMaintainsOutperform Feb 2022NeedhamMaintainsBuy View More Analyst Ratings for GMED View the Latest Analyst Ratings read more...
07.04.25 - 16:00
 GMED Stock May Benefit Following the Acquisition of Nevro (Zacks)
 
Globus Medical acquires Nevro Corp. to expand its presence in the $2.50 billion musculoskeletal market....
03.04.25 - 14:33
 Globus Medical completes acquisition of Nevro Corp. (GlobeNewswire EN)
 
AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition of Nevro Corp., a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain....
21.03.25 - 15:00
 GMED Stock Jumps 41.8% in a Year: What′s Behind the Rally? (Zacks)
 
Globus Medical's robust musculoskeletal offerings and synergies from the NuVasive merger are fueling its stock gains....
19.03.25 - 16:30
 Should You Hold Globus Medical Stock in Your Portfolio Now? (Zacks)
 
GMED stays on investors' radar due to its high NuVasive-merger synergies and solid Musculoskeletal prospects....
18.03.25 - 18:00
 New Product Launches Benefit GMED Stock Amid Macro Issues (Zacks)
 
Globus Medical currently awaits a strong cadence of product launches throughout the Musculoskeletal portfolio in the coming months of 2025....
11.03.25 - 21:42
 Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades (GlobeNewswire EN)
 
AUDUBON, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced two commercial launches:...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Der guckt die Bälle weg. - Fritz Walter
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!